Evercore Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Evercore Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-11,250	Closed	-$635K	–	1064
2015 Q3	$635K	Buy	11,250 +6,020	+115%	+$390K	0.03%	228
2015 Q2	$309K	Buy	5,230 +1,530	+41%	+$94.4K	0.01%	348
2015 Q1	$230K	Hold	3,700	–	–	0.01%	391
2014 Q4	$214K	Hold	3,700	–	–	0.01%	350
2014 Q3	$199K	Hold	3,700	–	–	0.01%	395
2014 Q2	$194K	Sell	3,700 -502	-12%	-$25.7K	0.01%	392
2014 Q1	$223K	Sell	4,202 -300	-7%	-$13.9K	0.01%	358
2013 Q4	$180K	Sell	4,502 -2,159	-32%	-$85K	0.01%	378
2013 Q3	$252K	Sell	6,661 -5,666	-46%	-$221K	0.01%	376
2013 Q2	$486K	Buy	+12,327	New	+$480K	0.03%	283

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Evercore Wealth Management's TEVA Position: Q4 2015 in Review

Evercore Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2015, closing a stake of 11,250 shares — an estimated $635K sold.

Evercore Wealth Management first reported a position in TEVA in Q2 2013 and held it in 10 quarters. The position peaked at $635K in Q3 2015. 876 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Evercore Wealth Management reported no remaining Teva Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Evercore Wealth Management sold 11,250 Teva Pharmaceuticals shares in Q4 2015, an estimated $635K.
Evercore Wealth Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 10 quarters.
Evercore Wealth Management's Teva Pharmaceuticals position peaked at $635K in Q3 2015.
876 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on Evercore Wealth Management's 13F filing for Q4 2015, filed 16 Feb 2016.